WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced it has entered into a settlement agreement in its U.S. SEROQUEL XR® patent infringement litigation against Handa ...

AstraZeneca’s bid to get another approval for Seroquel XR has been hit by news that US regulators require additional information on the drug as a treatment for anxiety. AstraZeneca’s bid to get ...

An AstraZeneca (AZN) executive warned in an internal email that the company's data did not show its antipsychotic drug Seroquel was superior to an older drug, Haldol, but the company promoted that ...

The XR in SEROQUEL XR stands for extended release. This means that medication is released around the clock. SEROQUEL XR is taken once daily as prescribed by your health care professional. SEROQUEL XR ...

AstraZeneca has received a miserable Christmas present from regulators in the USA who want more information before approving a new indication for the schizophrenia drug Seroquel. AstraZeneca has ...

AstraZeneca knew as far back as 1997 that Seroquel put patients at risk of weight gain, according to the company's own internal memos. The documents also appear to show that some AZ execs developed ...

TRENTON, N.J. -- Internal AstraZeneca reports and e-mails written by company officials show they knew a decade ago that their psychiatric drug Seroquel caused diabetes and major weight gain, ...

GlobalData's pharmaceuticals report, Seroquel - Analysis and Estimates from 2002 to 2020 provides Seroquel sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of ...

AstraZeneca agreed to pay $520 million and enter a five-year Corporate Integrity Agreement (CIA) to settle a federal case against the company for off-label marketing of Seroquel, the Departments of ...

SEROQUEL XR was launched for the treatment of schizophrenia in the US in 2007, and clinical development programs and regulatory filings are planned for a number of other indications. Important Safety ...

The first warning came a dozen years ago, when the Food and Drug Administration accused the drug company AstraZeneca of “false or misleading” information about health risks in the marketing material ...